Posted 5/4/2016 10:06 PM (GMT 0)
“A one milligram pill of the drug induced clinical remission at week eight,” said Sandborn. “Unlike other currently available drugs for inflammatory bowel disease, ozanimod can be orally administered and does not suppress the immune system to the point of increasing likelihood of infection or cancer.”
http://health.ucsd.edu/news/releases/Pages/2016-05-04-ozanimod-effective-for-treating-ulcerative-colitis.aspx